Table 3.
Incidence of Nd:YAG in acrylic AcrySof three piece and one piece IOLs
| IOL type | Eyes | Nd:YAG (%) | Mean follow up time (months) (range) | Study |
| MA30 | 335 | 9 (2.69) | 23.3 (18.7–30.3) | Stordahl12 |
| MA30 | 176 | 12 (6.8) | 32.8 (5.3–75.2) | Mian |
| MA30 | 156 | 17 (10.9) | 35.15 | Ernest25 |
| MA30 | 94 | 1 (1.06) | 12 | Bender24 |
| MA30 | 85 | 4 (4.71) | 13.6 | Scaramuzza11 |
| MA30 | 46 | 0 (0) | 19.35 | Halpern9 |
| MA60 | 485 | 12 (2.47) | 24 | Beltrame8 |
| MA60 | 127 | 1 (0.79) | 12 (11–14) | Mester7 |
| MA60 | 100 | 2 (2) | 24 | Hayashi6 |
| MA60 | 71 | 10 (14) | 35.4 (5.3–91.1) | Mian |
| MA60 | 62 | 3 (4.84) | 19.35 | Halpern9 |
| MA60 | 38 | 1 (2.63) | 18 | Prosdocimo27 |
| MA60 | 38 | 3 (7.89) | 24 | Wejde10 |
| MA60 | 21 | 0 (0) | 36 | Küçüksümer29 |
| MA30/MA60 | 216 | 2 (0.9) | Postmortem study | Apple20 |
| MA30/MA60 | 107 | 3 (2.8) | 37.08 | Missier21 |
| MA30/MA60 | 61 | 1 (1.64) | 48 | Ram28 |
| MA30/MA60 | 19 | 0 (0) | 36 | Hollick30 |
| SA30 | 2044 | 13 (0.64) | 9 (2–23) | Davison13 |
| SA30 | 45 | 2 (4.4) | 19.4 (6.1–37.5) | Mian |
| SA30 | 38 | 0 (0) | 12 | Bender24 |
| SA60 | 586 | 2 (0.34) | 5.5 (5–6) | Davison13 |
| SA60 | 142 | 12 (8.5) | 12.3 (5.1–26.0) | Mian |